Matinas BioPharma Holdings (MTNB) Net Cash Flow Growth (1y) (2014 - 2026)
Matinas BioPharma Holdings (MTNB) Net Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 198.34% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 467.41% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14,223.53% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 453.08% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - | -344.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -344.72% |
| Dec 31, 2025 | 52.31% |
| Sep 30, 2025 | -123.19% |
| Jun 30, 2025 | -112.69% |
| Mar 31, 2025 | 90.31% |
| Dec 31, 2024 | -85.86% |
| Sep 30, 2024 | 282.22% |
| Jun 30, 2024 | -21.45% |
| Mar 31, 2024 | -240.60% |
| Dec 31, 2023 | 62.72% |
| Sep 30, 2023 | -529.34% |
| Jun 30, 2023 | 144.84% |
| Mar 31, 2023 | 35.90% |
| Dec 31, 2022 | -11.66% |
| Sep 30, 2022 | 114.09% |
| Jun 30, 2022 | -228.11% |
| Mar 31, 2022 | -115.54% |
| Dec 31, 2021 | -173.01% |
| Sep 30, 2021 | 30.64% |
| Jun 30, 2021 | 44.41% |